PubRank

C Baigent

Author PubWeight™ 106.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005 32.41
2 Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 18.09
3 The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012 17.29
4 Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008 8.53
5 Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013 8.16
6 Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ 1998 6.13
7 Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ 1996 2.90
8 Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol 2000 2.22
9 Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ 2013 1.78
10 Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 2005 1.71
11 Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001 1.64
12 Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997 1.58
13 Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. J Intern Med 2010 1.47
14 Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. BMJ 1994 0.93
15 Benefit of heparin plus aspirin vs aspirin alone in unstable angina. JAMA 1996 0.86
16 Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013 0.84
17 Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure? Nephrol Dial Transplant 2000 0.78
18 Renal function: an emerging risk factor for cardiovascular disease? Evid Based Cardiovasc Med 2001 0.77
19 Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression. Br Heart J 1995 0.75
20 Benefit of aspirin plus angiotensin-converting enzyme inhibitor. J Am Coll Cardiol 2001 0.75
21 Immediate aspirin for suspected ischaemic stroke. Lancet 1999 0.75
22 Anesthesia in neonatal cardiac surgery. N Engl J Med 1992 0.75
23 Safety of metformin in Type 2 diabetes mellitus. Diabet Med 1999 0.75
24 [Duration of the phases of the cell cycle in L-929 cells (author's transl)]. Biophysik 1973 0.75
25 The combined action of thiourea and endogenous anoxia against x-ray induced cellular damage. Strahlentherapie 1973 0.75